Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Drug Trial News Stories - January 2010

Date Title Comments Rating
2010-01-30 Clinical results of MedImmune's pivotal trial for motavizumab published 0 None
2010-01-30 Perifosine holds promise as a single agent for relapsed/refractory Waldenstrom's Macroglobulinemia 0 None
2010-01-29 Positive Phase 2 trial results of Keryx Biopharmaceuticals' KRX-0401 announced 0 None
2010-01-29 New guidance may help minimize risks to patient privacy in clinical trials 0 None
2010-01-29 Diabetes vaccine: Diamyd Medical to file for market approval in 2011 0 None
2010-01-29 Merge Healthcare deploys etrials eDiary 5.0 platform for global urology clinical trial 0 None
2010-01-28 Conatus Pharmaceuticals initiates combination trial of CTS-1027 with pegylated interferon and ribavirin for HCV 0 None
2010-01-28 ChemoCentryx announces the initiation of Phase I clinical trial of CCX168 0 None
2010-01-28 Zelos Therapeutics commences dosing in clinical study of ZT-034 nasal spray for osteoporosis 0 None
2010-01-28 NIDA supports Omeros' Addiction program 0 None
2010-01-28 Neovasc to fund proceeds of its non-brokered private placement for COSIRA trial 0 None
2010-01-28 Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases 0 None
2010-01-28 Anacor Pharmaceuticals to present data on its PDE4 inhibitor at the Cytokines and Inflammation Conference 0 None
2010-01-28 Men welcome male contraceptive pill currently undergoing trials 0 None
2010-01-28 GENFIT's GFT505 exhibits potential to address unmet needs in prediabetic and diabetic patients 0 None
2010-01-27 Positive results from Supernus Pharmaceuticals' SPN 810 Phase IIa trial for ADHD 0 None
2010-01-27 GenSpera commences treatment in G-202 Phase I trial for solid tumors 0 None
2010-01-27 Eribis Pharmaceuticals' cardiovascular therapy program receives new investment from Karolinska Development 0 None
2010-01-27 Cornerstone Pharmaceuticals closes $6.17M Series B-4 private equity financing 0 None
2010-01-27 Suneva Medical to present interim data from its Artefill study for NLF correction at the Maui Derm 2010 0 None
2010-01-27 Osiris Therapeutics completes enrollment in Prochymal MSC therapy Phase II trial for type 1 diabetes 0 1
2010-01-27 Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection 0 None
2010-01-27 Curemark commences CM-AT Phase III autism clinical trial enrollment at ten sites 0 None
2010-01-27 YM BioSciences' nimotuzumab Phase II trials: FDA advises patient enrollment 0 None
2010-01-25 Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B 0 None
2010-01-24 Final data from Poniard Pharmaceuticals' randomized Phase 2 trial of picoplatin announced 0 None
2010-01-23 Pfizer reports final results from randomized Phase 3 trial of Sutent 0 None
2010-01-22 Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial 0 None
2010-01-22 Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced 0 None
2010-01-22 CMO to manufacture Gaia BioPharma's GAI-122 Mitochondria-targeted neuroprotective agent 0 None
2010-01-21 Ipsen and Inspiration Biopharmaceuticals form strategic partnership 0 None
2010-01-21 Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC 0 None
2010-01-21 China Pharma Holdings announces completion of clinical trials for Candesartan 0 None
2010-01-21 Elevation Pharmaceuticals closes $30M tranched Series A financing 0 None
2010-01-21 Pharmasset commences PSI-7977 Phase 2a trial for HCV 0 None
2010-01-21 BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial 0 None
2010-01-21 Results of two pivotal Phase III clinical trials with oral FTY720 published 0 None
2010-01-21 Phase 3 clinical trial results of Inspire Pharmaceuticals' PROLACRIA announced 0 None
2010-01-21 IMUC’s ICT-107 vaccine product candidate targets cancer stem cells 0 5
2010-01-21 EMD Serono announces results from CLARITY Phase III trial in MS patients 0 None
2010-01-21 Dosing in First-in-Man Phase I study of 4SC AG's 4SC-203 commenced 0 None
2010-01-20 Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients 0 None
2010-01-20 PROLOR Biotech's hGH-CTP Phase I study data to be presented at the BIO CEO & Investor Conference 0 None
2010-01-20 Telaprevir effective in HCV patients 4 3
2010-01-20 PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD 0 None
2010-01-20 Depomed plans additional Serada Phase 3 trial for treatment of menopausal hot flashes 0 None
2010-01-20 Patient enrollment for Phase 2B clinical study of Oramed Pharmaceuticals' ORMD-0801 completed 0 None
2010-01-20 Merck’s initiation of EMD 1201081-cetuximab combination Phase 2 trial triggers €3.0M milestone payment 0 None
2010-01-20 Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced 0 5
2010-01-19 CytoDyn commences enrollment in Cytolin clinical trial 0 None
2010-01-19 DURECT commences dosing in its POSIDUR Phase III clinical trial 0 None
2010-01-19 Circassia commences Phase II trials of its T-cell vaccines against house dust mite and cat allergies 0 None
2010-01-19 PCI Biotech AS completes second dose group in phase I/II study of Amphinex 0 None
2010-01-19 Enrollment of Phase 2 portion of Cempra Pharmaceuticals' Phase 2/3 clinical trial of TAKSTA completed 0 None
2010-01-18 New neuroprotective drug trial for people with traumatic brain injuries 0 None
2010-01-18 AVIR Green Hills Biotechnology commences deltaFLU Phase II study 1 None
2010-01-18 Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective 0 None
2010-01-17 Results from Bionovo's phase 1B clinical trial of Bezielle published 0 None
2010-01-13 Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1 0 5
2010-01-13 New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic 0 None
2010-01-13 Spectrum Pharmaceuticals achieves its enrollment target in second of two apaziquone Phase 3 trials 0 None
2010-01-12 Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed 0 None
2010-01-12 Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial 0 None
2010-01-12 Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer 0 None
2010-01-12 Phase I clinical trial of XRX-001 for yellow fever initiated 0 None
2010-01-12 Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV 0 None
2010-01-12 HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C 0 None
2010-01-12 Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion 0 None
2010-01-12 Salt Lake City research center joins international drug trial program for painful menstrual cramps 0 None
2010-01-12 CEL-SCI completes validation of its GMP manufacturing facility 0 None
2010-01-12 NicOx, TOPIGEN Pharmaceuticals terminate TPI 1020 collaboration 0 None
2010-01-12 Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine 0 None
2010-01-12 4SC commences treatment in its resminostat Phase II trial for HL 0 None
2010-01-12 Idenix Pharmaceuticals announces significant progress in HCV development programs 0 None
2010-01-12 Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA 0 None
2010-01-12 YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration 0 None
2010-01-12 Pfizer commences SBI-087 Phase 2 clinical trial for RA 0 None
2010-01-12 Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel 0 None
2010-01-12 Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD 0 None
2010-01-12 Interim results from Phase I clinical trials utilizing PLX-PAD for treatment of CLI reported 0 None
2010-01-12 BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD 0 None
2010-01-11 Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced 0 None
2010-01-11 Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics 0 None
2010-01-11 Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease 0 None
2010-01-11 New data from phase 3 study of avanafil for treatment of ED announced 3 5
2010-01-11 Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published 0 None
2010-01-11 Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy 0 None
2010-01-09 Results of randomized, placebo-controlled study of Ambrotose complex announced 0 None
2010-01-09 Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development 0 None
2010-01-09 LFB completes conversion of all acquired preferred stock 0 None
2010-01-09 Plexxikon commences dosing in PLX4032 Phase 3 trial for metastatic melanoma 0 3.2
2010-01-09 Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track 0 None
2010-01-08 Funxional Therapeutics completes Phase I study of FX125L 0 None
2010-01-08 TetraLogic Pharmaceuticals commences its TL32711 SMAC mimetic Phase 1 clinical trial 0 5
2010-01-08 Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancer 0 5
2010-01-08 Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study 0 None
2010-01-08 Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed 0 None
2010-01-08 University Hospitals Case Medical Center conducts Phase 2 clinical trial of gene therapy for AD 0 None
2010-01-08 Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced 0 5
2010-01-08 Initiation of double blind placebo controlled multi-center trial of DAS181 announced 0 None
2010-01-08 Pfizer and Debiopharm Group enter into co-development agreement to conduct Phase 3 trial of tremelimumab 0 None
2010-01-07 Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced 0 None
2010-01-07 Positive top-line results from Phase III study of aclidinium bromide announced 0 None
2010-01-07 BioVex's Phase 3 melanoma study amended to include first line patients 0 None
2010-01-07 Phase II clinical trial results of Liposome-Entrapped Paclitaxel announced 0 5
2010-01-07 Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective 0 None
2010-01-06 Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38 0 None
2010-01-06 Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206 0 None
2010-01-06 OncoGenex Pharmaceuticals receives grant funding for Phase 2 clinical trial of OGX-427 0 None
2010-01-06 Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results 0 None
2010-01-06 Patient enrolled in Phase I clinical study of two investigational compounds: MK-2206 and AZD6244 0 4
2010-01-06 Keryx Biopharmaceuticals reaches SPA agreement for Phase 3 clinical program for Zerenex 0 None
2010-01-06 Phase I clinical trial for Intellikine's INK128 inhibitor initiated 0 None
2010-01-06 Scott & White's CRI launches two clinical trials targeting cancers 0 None
2010-01-06 Excaliard Pharmaceuticals initiates Phase 2 trials of EXC 001 0 None
2010-01-06 EnVivo Pharmaceuticals announces initiation and dosing of patients in Phase 2b study of EVP-6124 0 None
2010-01-06 IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 0 None
2010-01-06 Cancer Research UK and CRT to undertake phase I clinical trial of DI-B4 0 None
2010-01-06 Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced 0 None
2010-01-05 DSMB recommends Quark Pharmaceuticals to continue clinical study of QPI-1002 0 None
2010-01-05 Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated 0 None
2010-01-05 Talampanel slows progression of amyotrophic lateral sclerosis 0 None
2010-01-04 Headline results from first phase III study of Balaglitazone announced 0 None
2010-01-04 DSPA submits lurasidone NDA to the FDA 0 None
2010-01-04 BioInvent International begins BI-505 drug study on patients with advanced multiple myeloma 0 None
2010-01-04 Novelos continues NOV-002 Phase 3 combination trial for lung cancer 0 5
2010-01-03 D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke 0 5

Total

127 posts
8 comments
26 raters